Genotype-Specific Differences in the Tumor Metabolite Profile of Pheochromocytoma and Paraganglioma Using Untargeted and Targeted Metabolomics

被引:30
作者
Rao, J. U. [1 ,2 ]
Engelke, U. F. H. [1 ]
Sweep, F. C. G. J. [1 ]
Pacak, K. [3 ]
Kusters, B. [4 ,9 ]
Goudswaard, A. G. [1 ]
Hermus, A. R. M. M. [2 ]
Mensenkamp, A. R. [5 ]
Eisenhofer, G. [6 ,7 ]
Qin, N. [6 ,7 ]
Richter, S. [6 ,7 ]
Kunst, H. P. M. [8 ]
Timmers, H. J. L. M. [2 ]
Wevers, R. A. [1 ]
机构
[1] Radboud Univ Nijmegen, Lab Genet Endocrine & Metab Dis, Dept Lab Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Endocrinol Sect, Dept Internal Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands
[3] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA
[4] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands
[5] Radboud Univ Nijmegen, Med Ctr, Dept Genet, NL-6525 ED Nijmegen, Netherlands
[6] Univ Hosp Carl Gustav Carus, Dept Med, Dresden, Germany
[7] Univ Hosp Carl Gustav Carus, Inst Clin Chem & Lab Med, Dresden, Germany
[8] Radboud Univ Nijmegen, Dept Otolaryngol, NL-6525 ED Nijmegen, Netherlands
[9] Maastricht Univ, Med Ctr, Dept Pathol, NL-6200 MD Maastricht, Netherlands
关键词
PURINE METABOLISM; IN-VIVO; H-1-NMR;
D O I
10.1210/jc.2014-2138
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context and Objective: Pheochromocytomas and paragangliomas (PGLs) are neuroendocrine tumors of sympathetic or parasympathetic paraganglia. Nearly 40% of PGLs are caused by germline mutations. The present study investigated the effect of genetic alterations on metabolic networks in PGLs. Design: Homogenates of 32 sporadic PGLs and 48 PGLs from patients with mutations in SDHB, SDHD, SDHAF-2, VHL, RET, and NF-1 were subjected to proton (H-1) nuclear magnetic resonance (NMR) spectroscopy at 500 MHz for untargeted and HPLC tandem mass spectrometry for targeted metabolite profiling. Results: 1H NMR spectroscopy identified 28 metabolites in PGLs of which 12 showed genotype-specific differences. Part of these results published earlier reported low complex II activity (P < .0001) and low ATP/ADP/AMP content (P < .001) in SDH-related PGLs compared with sporadics and PGLs of other genotypes. Extending these results, low levels of N-acetylaspartic acid (NAA; P < .05) in SDH tumors and creatine (P < .05) in VHL tumors were observed compared with sporadics and other genotypes. Positive correlation was observed between NAA and ATP/ADP/AMP content (P < .001) and NAA and complex II activity (P < .0001) of PGLs. Targeted purine analysis in PGLs showed low adenine in cluster 1 compared with cluster 2 tumors (SDH P < .0001; VHL P < .05) whereas lower levels (P < .05) of guanosine and hypoxanthine were observed in RET tumors compared with SDH tumors. Principal component analysis (PCA) of metabolites could distinguish PGLs of different genotypes. Conclusions: The present study gives a comprehensive picture of alterations in energy metabolism in SDH- and VHL-related PGLs and establishes the interrelationship of energy metabolism and amino acid and purine metabolism in PGLs.
引用
收藏
页码:E214 / E222
页数:9
相关论文
共 19 条
[11]   Genotype-Specific Abnormalities in Mitochondrial Function Associate with Distinct Profiles of Energy Metabolism and Catecholamine Content in Pheochromocytoma and Paraganglioma [J].
Rao, Jyotsna U. ;
Engelke, Udo F. H. ;
Rodenburg, Richard J. T. ;
Wevers, Ron A. ;
Pacak, Karel ;
Eisenhofer, Graeme ;
Qin, Nan ;
Kusters, Benno ;
Goudswaard, Angelina G. ;
Lenders, Jacques W. M. ;
Hermus, Ad R. M. M. ;
Mensenkamp, Arjen R. ;
Kunst, Henricus P. M. ;
Sweep, Fred C. G. J. ;
Timmers, Henri J. L. M. .
CLINICAL CANCER RESEARCH, 2013, 19 (14) :3787-3795
[12]   1H/13C MR spectroscopic imaging of regionally specific metabolic alterations after experimental stroke [J].
van der Zijden, Jet P. ;
van Eijsden, Pieter ;
de Graaf, Robin A. ;
Dijkhuizen, Rick M. .
BRAIN, 2008, 131 :2209-2219
[13]   Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas [J].
Welander, Jenny ;
Soderkvist, Peter ;
Gimm, Oliver .
ENDOCRINE-RELATED CANCER, 2011, 18 (06) :R253-R276
[14]   Hypoxia-induced metabolic shifts in cancer cells: Moving beyond the Warburg effect [J].
Weljie, Aalim M. ;
Jirik, Frank R. .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2011, 43 (07) :981-989
[15]   1H NMR metabolomics identification of markers of hypoxia-induced metabolic shifts in a breast cancer model system [J].
Weljie, Aalim M. ;
Bondareva, Alla ;
Zang, Ping ;
Jirik, Frank R. .
JOURNAL OF BIOMOLECULAR NMR, 2011, 49 (3-4) :185-193
[16]  
WEVERS RA, 1995, CLIN CHEM, V41, P744
[17]  
Wevers RA, 1999, CLIN CHEM, V45, P539
[18]  
Wishart DS, 2011, BIOANALYSIS, V3, P1769, DOI [10.4155/bio.11.155, 10.4155/BIO.11.155]
[19]  
Ziegler A, 2001, CANCER RES, V61, P5595